Papers of the Week

< BACK TO ARCHIVE

DATE PUBLISHED:
2020 Nov

JOURNAL:
J Manag Care Spec Pharm

PUBMED:
http://www.ncbi.nlm.nih.gov/pubmed/33119438?dopt=Abstract

Volume:
26

ISSUE:
11

ICER’s assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine.

Authors

ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine.

Franklin M, Druyts E

J Manag Care Spec Pharm. 2020 Nov; 26(11):1464-1466.

PMID: 33119438.

Abstract

No funding supported the writing of this commentary. The authors have nothing to disclose.

Read This Paper